Here’s a curated list of the best ET Wealth stories of the week. We take a look at the small finance bank stocks that could be the next money multiplier, 4 pharma stock With upside potential of up to 20%, how startup returns will be taxed, 4 pharma stocks worth betting on and much more.

1)
Could a small finance bank be the next HDFC Bank?

As a new chapter in Indian banking begins, is there another opportunity for equity investors to benefit from this model? If yes, which stock is best for you to invest for long term?

2)
How investors make less than what they invest

We investors are our own worst enemy. On one hand, we are obsessed with choosing the best mutual funds to invest in. On the other hand, we buy and sell funds at exactly the wrong time with the guarantee of reducing our returns.

3)
4 pharma stocks likely to rise up to 20%

Here is a list of four pharma companies that have good analyst recommendations and have double-digit one-year price potential.

4)
How small investors can invest money in startups, how tax will be imposed on the gains from investments

Few platforms are helping small investors gain a foothold in the over-risk-too-high-reward world of startup investing.

5)
4 reasons why analysts are bullish on HDFC Life

Higher awareness of the need for protection and the changing demographic of India, with the growing proportion of the insurable population, will lead to expansion. HDFC Life Insurance,